Cargando…
Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
BACKGROUND: Atrial fibrillation (AF) and renal impairment share a bidirectional relationship with important pathophysiological interactions. We evaluated the impact of renal impairment in a contemporary cohort of patients with AF. METHODS: We utilised the ESC‐EHRA EORP‐AF Long‐Term General Registry....
Autores principales: | Ding, Wern Yew, Potpara, Tatjana S., Blomström‐Lundqvist, Carina, Boriani, Giuseppe, Marin, Francisco, Fauchier, Laurent, Lip, Gregory Y. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287022/ https://www.ncbi.nlm.nih.gov/pubmed/35000206 http://dx.doi.org/10.1111/eci.13745 |
Ejemplares similares
-
Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022) -
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
por: Proietti, Marco, et al.
Publicado: (2021) -
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry
por: Proietti, Marco, et al.
Publicado: (2021) -
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
por: Romiti, Giulio Francesco, et al.
Publicado: (2022) -
Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry
por: van Rosmalen, Frank, et al.
Publicado: (2020)